Compare Amphastar Pharmaceuticals Inc (AMPH) vs BlackBerry Limited (BB) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

BlackBerry (BB) trades at $10.97, down 4.02% today, with a bullish technical outlook supported by moving averages. The company shows improving fundamentals with three consecutive quarterly EPS beats and projected profitability in 2026. Recent news highlights strong QNX growth in automotive and robotics sectors, though valuation metrics remain elevated with P/E at 109.7 and P/S at 11.26.

The outlook is cautiously optimistic as BlackBerry's turnaround gains traction with improved cash flow and QNX momentum. Key risks include execution challenges amid rich valuation and competitive pressures. Analyst consensus leans neutral with 85.7% hold ratings and $10.50 price target, suggesting limited near-term upside from current levels.